110 related articles for article (PubMed ID: 9433779)
21. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
22. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
Wade PR; Mawe GM; Branchek TA; Gershon MD
Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
[TBL] [Abstract][Full Text] [Related]
24. [3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.
Gordon JC; Barefoot DS; Sarbin NS; Pinkus LM
J Pharmacol Exp Ther; 1989 Dec; 251(3):962-8. PubMed ID: 2600824
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue.
Barnes JM; Barnes NM; Costall B; Ironside JW; Naylor RJ
J Neurochem; 1989 Dec; 53(6):1787-93. PubMed ID: 2809591
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of 6-chloro-3,4-dihydro-4-methyl-2H-1,4-benzoxazine-8-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists.
Kuroita T; Sakamori M; Kawakita T
Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):756-64. PubMed ID: 8681408
[TBL] [Abstract][Full Text] [Related]
27. Differential localization of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the human rectum.
Sakurai-Yamashita Y; Yamashita K; Yoshimura M; Taniyama K
Life Sci; 2000; 66(1):31-4. PubMed ID: 10658921
[TBL] [Abstract][Full Text] [Related]
28. The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system.
Kidd E; Bouchelet de Vendegies I; Levy JC; Hamon M; Gozlan H
Eur J Pharmacol; 1992 Jan; 211(1):133-6. PubMed ID: 1618262
[TBL] [Abstract][Full Text] [Related]
29. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of (S)-[(18)F]fesetron in the rat brain as a potential PET imaging agent for serotonin 5-HT3 receptors.
Pithia NK; Liang C; Pan XZ; Pan ML; Mukherjee J
Bioorg Med Chem Lett; 2016 Apr; 26(8):1919-24. PubMed ID: 26979158
[TBL] [Abstract][Full Text] [Related]
31. Association of [3H]zacopride with 5-HT3 binding sites.
Pinkus LM; Sarbin NS; Barefoot DS; Gordon JC
Eur J Pharmacol; 1989 Sep; 168(3):355-62. PubMed ID: 2583241
[TBL] [Abstract][Full Text] [Related]
32. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
[TBL] [Abstract][Full Text] [Related]
33. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
BolaƱos FJ; Schechter LE; Miquel MC; Emerit MB; Rumigny JF; Hamon M; Gozlan H
Biochem Pharmacol; 1990 Oct; 40(7):1541-50. PubMed ID: 2222509
[TBL] [Abstract][Full Text] [Related]
34. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
Waeber C; Pinkus LM; Palacios JM
Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
[TBL] [Abstract][Full Text] [Related]
35. Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cells.
Miquel MC; Emerit MB; Gozlan H; Hamon M
Biochem Pharmacol; 1991 Sep; 42(7):1453-61. PubMed ID: 1930269
[TBL] [Abstract][Full Text] [Related]
36. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
[TBL] [Abstract][Full Text] [Related]
37. Solubilization of a 5-HT3 binding site from rabbit small bowel muscularis membranes.
Gordon JC; Sarbin NS; Barefoot DS; Pinkus LM
Eur J Pharmacol; 1990 Jun; 188(6):313-9. PubMed ID: 2373145
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
[TBL] [Abstract][Full Text] [Related]
39. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
Steward LJ; West KE; Kilpatrick GJ; Barnes NM
Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T
Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]